An innovator in developing therapeutic antibodies and fusion proteins

Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. We have built several drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, and a platform for developing multispecific antibodies using Fibody and nanobodies. We have also built a differentiated pipeline of leading drug candidates. We have established capabilities that cover the entire drug development process from drug discovery, preclinical research, Chemistry, Manufacturing and Controls (CMC) to early clinical development. We are committed to enabling safer, more efficacious and affordable biologics.
Read more





R&D platforms on therapeutic antibodies


projects in the pipeline


patents worldwide



R&D and CMC facilities


Innovating for more efficient treatment of cancers and autoimmune diseases

We specialize in developing therapeutic antibodies and fusion proteins.
Read more


Pressing forward to combat cancers

We have developed an innovative and differentiated pipeline of biologics, with projects ranging from preclinical through CMC stages.

Read more


Moving forward together

Talent development is part of our long-term priority and corporate responsibility.

Read more

+86 769 86088555, Ext. 8018


3F–4F, Building 10, Dongguan–Taiwan Bio-Tech Collaborative Incubation Center, 1 Taoyuan Road, Dongguan, Guangdong Province, China

Scan and follow Fapon LinkedIn Page

© Guangdong Fapon Biopharma Inc. All rights reserved.

Guangdong ICP No. 2024177910-1